HPV Molecular Diagnostic

Abbott Has Received License in Canada for Realtime High Risk HPV Molecular Diagnostic Test
May 30, 2013
Global health care company Abbott has received license from the Medical Device Bureau of Health Canada for its RealTime High Risk HPV molecular diagnostic test to detect human papillomavirus (HPV), a primary cause of cervical cancer. The ...

Tags: health care, HPV Molecular Diagnostic